Mathieu Kerneis

Mathieu Kerneis is an interventional cardiologist at Pitie Salpetriere Hospital (Sorbonne University) and Investigator of the ACTION Study Group (www.action-coeur.org). He was member of the PERFUSE Study Group, at the Beth Israel Medical Center, Harvard Medical School in Boston. His research themes cover coronary diseases, thrombosis and acute myocarditis. Dr Kerneis is the principal investigator of the ongoing randomized controlled trial ARAMIS Study (Anakinra Versus Placebo for the Treatment of Acute Myocarditis)